Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at FAST's multiple
$6.5363.6% above market
0.94 ZNTL revenue / share×6.94x FAST P/S=$6.53
Market $3.99Implied $6.53
FAST · current priceP/S 6.94x
$49.60Latest market snapshot
Implied fair value · at ZNTL's multiple
$30.3138.9% below market
7.15 FAST revenue / share×4.24x ZNTL P/S=$30.31
Market $49.60Implied $30.31